Skip to main content
. Author manuscript; available in PMC: 2012 May 3.
Published in final edited form as: J Gastrointest Surg. 2008 Aug 16;12(11):1951–1960. doi: 10.1007/s11605-008-0640-6

Table 4.

Univariate Analysis for Factors Predictive of Overall Survival

Factor Number Median survival, months p Value
Age (continuous)a 95 0.42
Gender
 Male 53 41.7 0.30
 Female 42 50.1
Tumor type
 Carcinoid 57 45.0 0.84
 Islet cell 38 32.0
Disease presentation
 Synchronous 77 37.0 0.53
 Metachronous 18 48.7
Liver involvement
 Unilobar 8 81.6 0.47
 Bilobar 87 41.8
Primary tumor resection
 Yes 55 73.1 0.0002
 No 39 28.0
Resection/ablation mets
 Yes 22 65.6 0.11
 No 73 36.5
Octreotide
 Yes 46 48.6 0.85
 No 37 37.0
Chemotherapy
 Yes 25 39.1 0.71
 No 50 43.0
Embolization type
 HACE 46 50.1 0.62
 HAE 49 39.1

Significant values in bold type.

a

Log transformation